Sensei Biotherapeutics, Inc.盘中异动早盘股价大跌7.20%

市场透视2025-05-30

北京时间2025年05月30日22时19分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现波动，股价急速跳水7.20%。截至发稿，该股报0.284美元/股，成交量6160股，换手率0.02%，振幅4.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.86百万美元，每股收益-0.27美元，毛利-30000.00美元，市盈率-0.27倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2539273711?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-30 22:19","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2539273711","market":"us","top_or_hot":-1,"title":"Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌7.20%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月30日22时19分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现波动，股价急速跳水7.20%。截至发稿，该股报0.284美元/股，成交量6160股，换手率0.02%，振幅4.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.86百万美元，每股收益-0.27美元，毛利-30000.00美元，市盈率-0.27倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530221934a492fb70&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌7.20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSensei Biotherapeutics, Inc.盘中异动 早盘股价大跌7.20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-30 22:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530221934a492fb70&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月30日22时19分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现波动，股价急速跳水7.20%。截至发稿，该股报0.284美元/股，成交量6160股，换手率0.02%，振幅4.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.86百万美元，每股收益-0.27美元，毛利-30000.00美元，市盈率-0.27倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530221934a492fb70&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530221934a492fb70&s=b","article_id":"2539273711","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530221934a492fb70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2539273711","pubTimestamp":1748614774,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月30日22时19分，Sensei Biotherapeutics, Inc.股票出现波动，股价急速跳水7.20%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.80%。其相关个股中，Bioline Rx Ltd、Osr Holdings Inc C/Wts 09/02/2028 、Imunon, Inc.涨幅较大，Bioline Rx Ltd、Nucana Plc、Psyence Biomedical Ltd.较为活跃，换手率分别为465.91%、220.63%、112.39%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为49.50%、46.81%、43.98%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc是一家专注于为癌症患者发现和开发下一代疗法的免疫肿瘤学公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","SNSE":"Sensei Biotherapeutics, Inc."},"translate_title":"Sensei Biotherapeutics, Inc. shares tumbled 7.20% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNSE":1},"content_text":"北京时间2025年05月30日22时19分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现波动，股价急速跳水7.20%。截至发稿，该股报0.284美元/股，成交量6160股，换手率0.02%，振幅4.45%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.86百万美元，每股收益-0.27美元，毛利-30000.00美元，市盈率-0.27倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.80%。其相关个股中，Bioline Rx Ltd、Osr Holdings Inc C/Wts 09/02/2028 (To Pur Com)、Imunon, Inc.涨幅较大，Bioline Rx Ltd、Nucana Plc、Psyence Biomedical Ltd.较为活跃，换手率分别为465.91%、220.63%、112.39%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Abpro Holdings Inc C/Wts 12/11/2029 (To Pur Com)、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)，振幅分别为49.50%、46.81%、43.98%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc是一家专注于为癌症患者发现和开发下一代疗法的免疫肿瘤学公司。其TMAb（肿瘤微环境激活生物制剂）平台正在开发选择性疗法，旨在在肿瘤微环境中选择性地禁用免疫抑制信号或激活免疫刺激信号。该公司有四个在不同开发阶段的研究产品候选者：SNS-101（VISTA）、SNS-102（VSIG4）、SNS-103（ENTPDase/CD39）、SNS-201（VISTAxCD28）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2539273711","isCrawlerRequest":true}

Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌7.20%

精彩评论

Sensei Biotherapeutics, Inc.盘中异动早盘股价大跌7.20%